말초동맥 질환(PAD) 시장 규모는 2024년에 58억 5,000만 달러로 평가되며, 2025년 64억 6,000만 달러에서 2033년까지 142억 5,000만 달러로 성장할 전망입니다. 예측 기간(2026-2033년)의 CAGR은 10.4%로 예측됩니다.
시장 조사에 따르면 미국에서는 40세 이상 약 650만 명이 말초동맥질환(PAD)의 영향을 받고 있으며, 남녀 모두 발병률이 높지만, 특히 아프리카계 미국인의 발병률이 높은 것으로 나타났습니다. 고령화는 PAD의 유병률 증가에 중요한 역할을 하고 있으며, 혈관질환의 위험은 나이가 들수록 증가합니다. 또한 인구 통계학적 변화와 더불어 PAD 진단 및 치료 솔루션에 대한 혁신과 승인도 증가하고 있습니다. 이러한 요소들이 복합적으로 작용하여 말초동맥질환의 전반적인 위험 환경을 악화시키고 있습니다. 고령화, 질병률 증가, 기술 발전의 조합은 미국 헬스케어 시장에서 PAD와 관련된 복잡하고 진화하는 위험 요인을 부각시키고 있습니다.
말초동맥질환 시장 성장 촉진요인
당뇨병과 고혈압을 앓고 있는 노인 인구 증가는 말초동맥질환(PAD) 시장 성장의 중요한 원동력이 되고 있습니다. 노인은 특히 혈관 합병증 위험이 높으며, 이러한 만성질환의 존재는 PAD 발병 위험을 현저히 증가시킵니다. 당뇨병과 고혈압은 동맥의 협착과 경화를 촉진하여 사지로의 혈류를 심각하게 제한합니다. 결과적으로, 고령화 인구의 이러한 건강 문제 증가는 시장 역학에 직접적인 영향을 미쳐 효과적인 PAD 치료법 및 중재에 대한 수요를 증가시키고 있습니다.
말초동맥질환 시장 성장 억제요인
말초동맥질환(PAD)의 재발성은 시장 성장 가능성에 심각한 도전이 될 수 있습니다. 치료 옵션이 개선되고 있음에도 불구하고 PAD의 재발 위험은 지속적인 시장 발전을 가로막고 있습니다. 또한 업계의 제품 리콜 문제는 이러한 문제를 더욱 악화시킬 수 있습니다. 리콜은 소비자의 신뢰를 떨어뜨리고 규제 당국의 관심을 끌며 시정 조치를 요구하므로 전체 시장의 성장과 안정성을 저해할 수 있습니다. 이러한 장애물을 효과적으로 극복하기 위해서는 이해관계자들이 협력하여 질병 관리 및 제품 안전과 관련된 복잡한 문제를 해결하고 말초동맥질환 치료 솔루션의 지속적인 발전을 촉진하기 위해 협력해야 합니다.
말초동맥질환(PAD) 시장 동향
말초동맥질환(PAD) 시장은 질병 발생률 증가와 혁신적인 제품 승인 증가에 힘입어 눈에 띄는 상승세를 보이고 있습니다. PAD 환자의 급증은 고급 진단 및 치료 옵션에 대한 수요를 부각시키며 시장 성장을 가속하고 있습니다. 의료 기술의 지속적인 발전은 PAD의 다면적인 문제를 해결하기 위한 새로운 솔루션의 길을 열어 환자 치료와 치료 결과를 개선하는 데 기여하고 있습니다. 또한 규제 당국이 계속해서 획기적인 치료법을 승인함에 따라 시장은 이러한 진전을 활용하여 이해관계자와 의료 서비스 프로바이더 모두에게 풍요로운 시장 환경을 조성할 것으로 예측됩니다.
Peripheral Artery Disease Market size was valued at USD 5.85 Billion in 2024 and is poised to grow from USD 6.46 Billion in 2025 to USD 14.25 Billion by 2033, growing at a CAGR of 10.4% during the forecast period (2026-2033).
Market insights reveal that around 6.5 million individuals aged 40 and older in the U.S. are impacted by Peripheral Artery Disease (PAD), affecting both genders with a notably higher incidence among African Americans. The aging population plays a critical role in the growing prevalence of PAD, as the risk of vascular diseases increases with age. Furthermore, the demographic shift is paralleled by a rise in innovations and approvals for diagnostics and treatment solutions for PAD. These elements converge to enhance the overall risk landscape for peripheral arterial disease. The combination of an aging populace, increasing disease rates, and technological advancements highlights the complex and evolving risk factors associated with PAD in the U.S. healthcare market.
Top-down and bottom-up approaches were used to estimate and validate the size of the Peripheral Artery Disease market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Peripheral Artery Disease Market Segments Analysis
Global Peripheral Artery Disease Market is segmented by Type, Treatment, Disease, Route of Administration, End User and region. Based on Type, the market is segmented into Peripheral Angioplasty Balloons, Plaque Modification Devices, Peripheral Stents, Peripheral Catheters, Hemodynamic Flow Alteration Devices, Inferior Vena Cava (IVC) Filters and Peripheral Accessories. Based on Treatment, the market is segmented into Device, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Others. Based on Disease, the market is segmented into Lipid Lowering Drugs, Triple-H Therapy, Glucose Regulating Drugs, Blood Clot Preventing Drugs,, Inotropes,, Thrombolytic Agents, and Anti-Inflammatory Agents. Based on Route of Administration, the market is segmented into Oral, Parenteral and Others. Based on End User, the market is segmented into Hospitals & Clinics and Ambulatory Surgical Clinics. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Peripheral Artery Disease Market
The rising prevalence of elderly individuals affected by diabetes and hypertension is a crucial driving force behind the growth of the peripheral artery disease (PAD) market. Older adults are especially vulnerable to vascular complications, and the presence of these chronic conditions significantly heightens the risk of developing PAD. Diabetes and high blood pressure contribute to the narrowing and hardening of arteries, which severely restricts blood flow to the limbs. As a result, the increasing incidence of these health issues within the aging population is directly influencing market dynamics and creating a heightened demand for effective PAD treatments and interventions.
Restraints in the Peripheral Artery Disease Market
The recurring nature of peripheral artery disease (PAD) poses a significant challenge to the market's growth potential. Despite improvements in treatment options, the risk of PAD reappearing continues to hinder sustained market progression. Additionally, issues surrounding product recalls in the industry may further exacerbate these challenges. Such recalls can undermine consumer confidence, draw regulatory attention, and necessitate remedial actions, all of which can stifle overall market growth and stability. To effectively navigate these obstacles, stakeholders must collaboratively address the intricate issues related to managing the disease and ensuring product safety, thereby fostering ongoing advancements in solutions for peripheral artery disease.
Market Trends of the Peripheral Artery Disease Market
The Peripheral Artery Disease (PAD) market is witnessing a notable upward trend driven by the rising incidence of the condition alongside an influx of innovative product approvals. This surge in PAD cases underscores the demand for advanced diagnostic and therapeutic options, catalyzing market growth. The ongoing advancements in medical technologies are paving the way for new solutions that address the multifaceted challenges of PAD, enhancing patient care and outcomes. Furthermore, as regulatory bodies continue to endorse groundbreaking treatments, the market is expected to capitalize on these developments, fostering a landscape rich in opportunities for stakeholders and healthcare providers alike.